$VMNT
Vemanti Group, Inc.

2021 Q4 Form 10-K Financial Statement

#000147793222001600 Filed on March 24, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $36.91K $148.0K
YoY Change -8.84%
Cost Of Revenue $5.990K $22.24K
YoY Change -38.25%
Gross Profit $30.92K $125.7K
YoY Change -0.45%
Gross Profit Margin 83.77% 84.97%
Selling, General & Admin $563.9K $1.742M
YoY Change 726.75%
% of Gross Profit 1823.84% 1385.65%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $180.00 $741.00
YoY Change 0.0%
% of Gross Profit 0.58% 0.59%
Operating Expenses $563.9K $1.742M
YoY Change 726.75%
Operating Profit -$533.0K -$1.616M
YoY Change 1814.56%
Interest Expense -$3.890K -$5.540K
YoY Change -34.82%
% of Operating Profit
Other Income/Expense, Net $0.00 -$1.754K
YoY Change -109.92%
Pretax Income -$533.0K -$1.623M
YoY Change 2058.07%
Income Tax $30.00 $1.650K
% Of Pretax Income
Net Earnings -$533.0K -$1.625M
YoY Change 2013.95%
Net Earnings / Revenue -1444.16% -1098.43%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share -$0.01 $0.00
COMMON SHARES
Basic Shares Outstanding 70.30M shares 69.70M shares
Diluted Shares Outstanding 69.70M shares

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $302.0K $302.0K
YoY Change 24.05%
Cash & Equivalents $295.9K $243.5K
Short-Term Investments $6.110K $6.110K
Other Short-Term Assets $0.00
YoY Change
Inventory
Prepaid Expenses $0.00
Receivables $4.415K $4.420K $1.224K
Other Receivables $25.14K $25.14K
Total Short-Term Assets $331.6K $331.6K $269.2K
YoY Change 23.17% 23.17%
LONG-TERM ASSETS
Property, Plant & Equipment $632.00 $630.00 $1.373K
YoY Change -53.97% -54.01%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $296.4K $296.4K $298.1K
YoY Change -0.55% -0.55%
Total Long-Term Assets $297.0K $297.0K $299.4K
YoY Change -0.8% -0.8%
TOTAL ASSETS
Total Short-Term Assets $331.6K $331.6K $269.2K
Total Long-Term Assets $297.0K $297.0K $299.4K
Total Assets $628.6K $628.6K $568.6K
YoY Change 10.55% 10.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.502K $4.500K $1.077K
YoY Change 318.01% 316.67%
Accrued Expenses $427.3K $427.3K $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $125.0K $125.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $556.8K $556.8K $1.690K
YoY Change 32846.45% 32846.75%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $556.8K $556.8K $1.690K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $556.8K $556.8K $1.690K
YoY Change 32846.45% 32846.75%
SHAREHOLDERS EQUITY
Retained Earnings -$3.284M -$1.659M
YoY Change 97.96%
Common Stock $7.040K $6.898K
YoY Change 2.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $71.84K $71.84K $567.0K
YoY Change
Total Liabilities & Shareholders Equity $628.6K $628.6K $568.6K
YoY Change 10.55% 10.55%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$533.0K -$1.625M
YoY Change 2013.95%
Depreciation, Depletion And Amortization $180.00 $741.00
YoY Change 0.0%
Cash From Operating Activities -$131.9K -$477.6K
YoY Change 534.1%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $10.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 -$10.00K
YoY Change -105.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $415.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 $540.0K
YoY Change
NET CHANGE
Cash From Operating Activities -131.9K -$477.6K
Cash From Investing Activities 0.000 -$10.00K
Cash From Financing Activities 0.000 $540.0K
Net Change In Cash -131.9K $62.44K
YoY Change -182.91%
FREE CASH FLOW
Cash From Operating Activities -$131.9K -$477.6K
Capital Expenditures $0.00 $10.00K
Free Cash Flow -$131.9K -$487.6K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 vemanti Loan From Shareholder
LoanFromShareholder
0 USD
CY2021 dei Auditor Firm
AuditorFirmId
820
CY2021Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
6107 USD
CY2020Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
0 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
296405 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
298056 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4502 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1077 USD
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 USD
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
613 USD
CY2021Q4 vemanti Loan From Shareholder
LoanFromShareholder
125000 USD
CY2021 us-gaap Gross Profit
GrossProfit
125709 USD
CY2020 us-gaap Gross Profit
GrossProfit
126276 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1741885 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
210691 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
1741885 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
210691 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-1616176 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-84415 USD
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
22241 USD
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1754 USD
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
17690 USD
CY2021 us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
-5544 USD
CY2020 us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
-8503 USD
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-7298 USD
CY2020 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
9187 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1623474 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-75228 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1650 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1648 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1625124 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-76876 USD
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69697059 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68984086 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69697059 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68984086 shares
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-76876 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
566955 USD
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
715012 USD
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
415000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1625124 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
71843 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-76876 USD
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
741 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
741 USD
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
1651 USD
CY2020 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
8503 USD
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
3893 USD
CY2020 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1142305 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
0 USD
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3191 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1011 USD
CY2021 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-644 USD
CY2020 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-7389 USD
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
0 USD
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2078 USD
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-613 USD
CY2020 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
613 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-477557 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-75312 USD
CY2021 us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
10000 USD
CY2020 us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
0 USD
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
CY2020 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
200000 USD
CY2021 us-gaap Proceeds From Loans
ProceedsFromLoans
125000 USD
CY2020 us-gaap Proceeds From Loans
ProceedsFromLoans
0 USD
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
415000 USD
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
540000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
CY2021 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
52443 USD
CY2020 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
124688 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
243494 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118806 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
295937 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
243494 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
25 USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1665 USD
CY2021 vemanti Accrued Stock Based Compensation
AccruedStockBasedCompensation
427293 USD
CY2020 vemanti Accrued Stock Based Compensation
AccruedStockBasedCompensation
0 USD
CY2014Q1 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
1 pure
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
40000000 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40000000 shares
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1625124 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-76876 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-477557 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-75312 USD
CY2021Q4 vemanti Working Capital
WorkingCapital
225194 USD
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Use of Estimates </span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates made by management include, among others, revenue recognition, recoverability of accounts receivable, and investments. Actual results could differ from those estimates. It is possible that accounting estimates and assumptions may be material to the Company due to the levels of subjectivity and judgment involved.</p>
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
3893 USD
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2021Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
6107 USD
CY2020Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
0 USD
CY2020Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
0 USD
CY2019Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
0 USD
CY2021 vemanti Purchase Of Crypto Currencies
PurchaseOfCryptoCurrencies
10000 USD
CY2020 vemanti Purchase Of Crypto Currencies
PurchaseOfCryptoCurrencies
0 USD
CY2021 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0 USD
CY2020 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
49268 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
49268 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
48636 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
47895 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
632 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1373 USD
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
40000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
70404086 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
68984086 shares
CY2021 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
555000 shares
CY2021 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
415000 USD
CY2021Q4 vemanti Federal Statutory Rates
FederalStatutoryRates
-340930 USD
CY2021 vemanti Federal Statutorypercentage
FederalStatutorypercentage
0.210 pure
CY2020Q4 vemanti Federal Statutory Rates
FederalStatutoryRates
-15798 USD
CY2020 vemanti Federal Statutorypercentage
FederalStatutorypercentage
0.210 pure
CY2021Q4 vemanti State Income Tax
StateIncomeTax
1650 USD
CY2021 vemanti State Income Taxes Rates
StateIncomeTaxesRates
0.088 pure
CY2020Q4 vemanti State Income Tax
StateIncomeTax
-6620 USD
CY2020 vemanti State Income Taxes Rates
StateIncomeTaxesRates
0.088 pure
CY2021Q4 vemanti Permanent Differences Income Tax
PermanentDifferencesIncomeTax
1256 USD
CY2021 vemanti Permanent Differences Rates
PermanentDifferencesRates
0.2100 pure
CY2020Q4 vemanti Permanent Differences Income Tax
PermanentDifferencesIncomeTax
946 USD
CY2020 vemanti Permanent Differences Rates
PermanentDifferencesRates
0.2100 pure
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
339674 USD
CY2021 vemanti Valuation Allowance Rate
ValuationAllowanceRate
-0.2972 pure
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
21472 USD
CY2020 vemanti Valuation Allowance Rate
ValuationAllowanceRate
-0.2854 pure
CY2021Q4 vemanti Effective Rate Income Tax
EffectiveRateIncomeTax
1650 USD
CY2021 vemanti Effective Rate Income Taxpercentage
EffectiveRateIncomeTaxpercentage
0.000 pure
CY2020Q4 vemanti Effective Rate Income Tax
EffectiveRateIncomeTax
0 USD
CY2020 vemanti Effective Rate Income Taxpercentage
EffectiveRateIncomeTaxpercentage
0.000 pure
CY2021 vemanti Net Operating Loss Carryforward Percentage
NetOperatingLossCarryforwardPercentage
1 pure
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2679077 USD
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1132304 USD
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
25142 USD
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
24498 USD

Files In Submission

Name View Source Status
0001477932-22-001600-index-headers.html Edgar Link pending
0001477932-22-001600-index.html Edgar Link pending
0001477932-22-001600.txt Edgar Link pending
0001477932-22-001600-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vemanti-20211231.xsd Edgar Link pending
vemanti-20211231_cal.xml Edgar Link unprocessable
vemanti-20211231_def.xml Edgar Link unprocessable
vemanti-20211231_lab.xml Edgar Link unprocessable
vemanti-20211231_pre.xml Edgar Link unprocessable
vemanti_10k.htm Edgar Link pending
vemanti_10kimg1.jpg Edgar Link pending
vemanti_10k_htm.xml Edgar Link completed
vemanti_ex211.htm Edgar Link pending
vemanti_ex311.htm Edgar Link pending
vemanti_ex312.htm Edgar Link pending
vemanti_ex321.htm Edgar Link pending
vemanti_ex322.htm Edgar Link pending